Hepatitis C in Developing Countries

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.

Autorentext
Professor Sanaa Kamal works at the Department of Gastroenterology and Hepatology within in the Ain Shams Faculuty of Medicine. She is a leading authority on the treatment and stidy of hepatitis C.

Klappentext

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.

Inhalt

1. Global Burden of Hepatitis C
   Section 1.1 The Public Health and Health Care Burden of Hepatitis C Infection
   Section 1.2 The Economic Burden of Hepatitis C Infection
   Section 1.3 The Social Burden of Hepatitis C Infection

   2. The Epidemic of Hepatitis C in Developing Countries
      Section 2.1 HCV Statistics in Developing Countries
      Section 2.2 The Growing Challenge of Hepatitis C in Developing Countries
      Subsection 2.2.a Epidemiology of Hepatitis C in Developing Countries
      Subsection 2.2.b Modes of Transmission of Hepatitis C in Developing Countries
      Subsection 2.2 c Socio-political Aspects of Hepatitis C in Developing Countries
      Subsection 2.2.d. Hepatitis C Genotypes in Developing Countries
      Subsection 2.2 e. Clinical Patterns and Complications of Hepatitis C Infection in Developing Countries
      Subsection 2.2.e Access to Hepatitis C Treatment in Developing Countries
      Subsection 2.2.f. Impact of Coinfections on Hepatitis C in Developing Countries
      Section 2.3 Macro and Micro-economics of Hepatitis C in Developing Countries

   3. The Magnitude of Hepatitis C Problem in Specific Regions
      Section 3.1 Hepatitis C in Egypt
      Section 3.2 Hepatitis C in Africa
      Section 3.3 Hepatitis C in the Middle East
      Section 3.1 Hepatitis C in Indian Subcontinent
      Section 3.2 Hepatitis C in Latin America
      Section 3.3 Hepatitis C in Southeast Asia

   4. Challenges of Hepatitis C in Developing Countries
      Section 4.1 Direct Acting Antiviral Agents in Developing Countries
      Section 4.2 Challenges of Producing Drugs and Potential Vaccines for Hepatitis C Specifically for Developing Countries
      Section 4.3 Ethics of Hepatitis C Clinical Trials and Research in Developing Countries
      Section 4.4 Applications of Genetics in Developing Countries
      Section 4.5 Hepatitis C Surveillance and Prevention in Developing Countries